Failure of Chemotherapy in Hepatocellular Carcinoma Due to Impaired and Dysregulated Primary Liver Drug Metabolizing Enzymes and Drug Transport Proteins: What to Do?-Reference-Cited by-同舟云学术

Failure of Chemotherapy in Hepatocellular Carcinoma Due to Impaired and Dysregulated Primary Liver Drug Metabolizing Enzymes and Drug Transport Proteins: What to Do?

Published:2018-09-14 Issue:10 Volume:19 Page:819-829
ISSN:1389-2002
Container-title:Current Drug Metabolism
language:en
Short-container-title:CDM

Author:

Ul-Islam Salman¹,Ahmed Muhammad Bilal¹,Shehzad Adeeb²,Ul-Islam Mazhar³,Lee Young Sup¹

Affiliation:

1. School of Life Sciences, College of Natural Sciences, Kyungpook National University, 41566, Korea

2. Department of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering, National University of Sciences and Technology Islamabad, Pakistan

3. Department of Chemical Engineering, College of Engineering, Dhofar University, Salalah, Oman

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Pharmacology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in drug resistance of triple negative breast cancer caused by pregnane X receptor;World Journal of Clinical Oncology;2023-09-24

2. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification;BMC Complementary Medicine and Therapies;2022-03-02

3. Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma;Biochemical Pharmacology;2021-06

4. MicroRNA in HCC: Biomarkers and Therapeutic Targets;Oncologie;2021

5. Nanocurcumin: A Double-Edged Sword for Microcancers;Current Pharmaceutical Design;2020-12-24